Kirkland & Ellis acted as legal advisers to EW Healthcare Partners on the transaction.
Healthcare-focused investor, EW Healthcare Partners, announced the acquisition of a majority stake in Grundium Oy, a Finland-based company that produces high-precision smart, connected and portable digital microscope scanners for diagnostic pathology. The founders and management of Grundium will retain a significant minority stake in Grundium and will work closely with EW Healthcare in continuing to drive revenue and EBITDA growth.
With close to $4 billion raised since inception, EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe.
A global leader in advanced imaging technology, Grundium makes digital pathology and high-quality professional diagnosis available for all life – whether human, animal, plant or other. This is achieved by doing something that nobody else can: applying state-of-the-art mobile technology in microscopy. Established in 2015 by ex-Nokia engineers, the Tampere-based company is democratizing digital pathology with the Ocus® range of microscope scanners.
The Kirkland team was led by corporate partner Aprajita Dhundia (Picture) and associates Sharon Skipper, Victoria Legg and Yoana Georgieva, tax partner Peter Abbott, technology & IP transaction partner John Patten and ESG & impact partner Ruth Knox.
Involved fees earner: Peter Abbott – Kirkland & Ellis; Aprajita Dhundia – Kirkland & Ellis; Yoana Georgieva – Kirkland & Ellis; Ruth Knox – Kirkland & Ellis; Victoria Legg – Kirkland & Ellis; John Patten – Kirkland & Ellis; Sharon Skipper – Kirkland & Ellis;
Law Firms: Kirkland & Ellis;
Clients: EW Healthcare Partners;